AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
1.750
+0.010 (0.57%)
May 20, 2025, 4:00 PM - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $173.15 million as of May 21, 2025. Its market cap has decreased by -26.97% in one year.
Market Cap
173.15M
Enterprise Value
14.27M
1-Year Change
-26.97%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $173.15M, a decrease of -80.04%. That is a compound annual growth rate of -16.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 175.70M | -34.83% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.89B |
| Johnson & Johnson | 366.90B |
| AbbVie | 328.04B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.56B |
| Abbott Laboratories | 235.83B |
| AstraZeneca | 214.95B |
| Novartis AG | 213.43B |